Introduction

Brain Pathology

Volumn 26, Issue 2, 2016, Pages 224-226

  Bendotti, Caterina ^a   Bonetto, Valentina ^a   Migheli, Antonio ^b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b ASL TO2   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; EDITORIAL; GENETIC LINKAGE; HUMAN; MOTONEURON; NONHUMAN; TRANSGENIC MOUSE; ANIMAL; GENETICS; LITERATURE; PATHOLOGY; PATHOPHYSIOLOGY;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; HUMANS; REVIEW LITERATURE AS TOPIC;

EID: 84961805947     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12349     Document Type: Editorial

References (20)

1. Appel SH, Zhao W, Beers DR, Henkel JS, (2011) The microglial-motoneuron dialogue in ALS. Acta Myol 30: 4-8.
2. Bendotti C, Carri MT, (2004) Lessons from models of SOD1-linked familial ALS. Trends Mol Med 10: 393-400.
3. Kwon I, Xiang S, Kato M, Wu L, Theodoropoulos P, Wang T, et al, (2014) Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells. Science 345: 1139-1145.
4. Lattante S, Ciura S, Rouleau GA, Kabashi E, (2015) Defining the genetic connection linking amyotrophic lateral sclerosis (ALS) with frontotemporal dementia (FTD). Trends Genet 31: 263-273.
5. Loeffler JP, Picchiarelli G, Dupuis L, Gonzalez De, Aguilar J-L, (2016) The role of skeletal muscle in amyotrophic lateral sclerosis. Brain Pathol 26: 227-236.
6. Mackenzie IR, Frick P, Neumann M, (2014) The neuropathology associated with repeat expansions in the C9ORF72 gene. Acta Neuropathol 127: 347-357.
7. Marino M, Papa S, Crippa V, Nardo G, Peviani M, Cheroni C, et al, (2015) Differences in protein quality control correlate with phenotype variability in 2 mouse models of familial amyotrophic lateral sclerosis. Neurobiol Aging 36: 492-504.
8. McGoldrick P, Joyce PI, Fisher EM, Greensmith L, (2013) Rodent models of amyotrophic lateral sclerosis. Biochim Biophys Acta 1832: 1421-1436.
9. Myszczynska M, Ferraiuolo L, (2016) New in vitro models to study amyotrophic lateral sclerosis. Brain Pathol 26: 258-264.
10. Nardo G, Trolese MC, Tortarolo M, Vallarola A, Freschi M, Pasetto L, et al, (2016) New insights on the mechanisms of disease course variability in ALS from mutant SOD1 mouse models. Brain Pathol 26: 237-247.
11. Peters OM, Ghasemi M, Brown RH Jr, (2015) Emerging mechanisms of molecular pathology in ALS. J Clin Invest 125: 1767-1779.
12. Pfohl SR, Halicek MT, Mitchell CS, (2015) Characterization of the contribution of genetic background and gender to disease progression in the SOD1 G93A mouse model of amyotrophic lateral sclerosis: a meta-analysis. J Neuromuscul Dis 2: 137-150.
13. Philips T, Rothstein JD, (2015) Rodent models of amyotrophic lateral sclerosis. Curr Protoc Pharmacol 69: 5.67.1-5.67.21.
14. Pradat PF, Kabashi E, Desnuelle C, (2015) Deciphering spreading mechanisms in amyotrophic lateral sclerosis: clinical evidence and potential molecular processes. Curr Opin Neurol 28: 455-461.
15. Puentes F, Malaspina A, vanNoort J, Amor S, (2016) Non-neuronal cells in ALS: role of glial, immune cells and blood-CNS barriers. Brain Pathol 26: 248-257.
16. Pupillo E, Messina P, Logroscino G, Beghi E, (2014) Long-term survival in amyotrophic lateral sclerosis: a population-based study. Ann Neurol 75: 287-297.
17. Rossi S, Cossolino M, Carrì MT, (2016) Old versus new mechanisms in the pathogenesis of ALS. Brain Pathol 26: 275-285.
18. Sabatelli M, Marangi G, Conte A, Tasca G, Zollino M, Lattante S, (2016) New ALS-related genes expand the spectrum paradigm of amyotrophic lateral sclerosis. Brain Pathol 26: 265-274.
19. Strong MJ, Kesavapany S, Pant HC, (2005) The pathobiology of amyotrophic lateral sclerosis: a proteinopathy? J Neuropathol Exp Neurol 64: 649-664.
20. Zhang K, Donnelly CJ, Haeusler AR, Grima JC, Machamer JB, Steinwald P, et al, (2015) The C9orf72 repeat expansion disrupts nucleocytoplasmic transport. Nature 525: 56-61.